Data / Form D filings / GLOBEIMMUNE INC
GLOBEIMMUNE INC: Form D filings
GLOBEIMMUNE INC, a pharmaceuticals company in Louisville, CO, filed 8 Form D notices with the SEC between 2009 and 2017. The latest, on March 23, 2017, reports $2.1 million sold of a $2.1 million offering to 1 investor.
Find out what GLOBEIMMUNE INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1450 INFINITE DRIVE, Louisville, CO, 80027
- Phone
- (303) 625-2744
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1245104
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 23, 2017 | New notice | $2,100,000 | $2,100,000 | $0 | 1 | Mar 20, 2017 | sec.gov |
| Jun 10, 2014 | Amendment | $7,500,000 | $7,500,000 | $0 | 110 | Jan 31, 2014 | sec.gov |
| Mar 12, 2014 | New notice | $391,730 | $391,730 | $0 | 1 | Nov 12, 2013 | sec.gov |
| Feb 13, 2014 | New notice | $7,500,000 | $7,500,000 | $0 | 92 | Jan 31, 2014 | sec.gov |
| Feb 3, 2010 | Amendment | $17,999,124 | $17,999,124 | $0 | 27 | Jan 14, 2010 | sec.gov |
| Jan 27, 2010 | New notice | $17,999,124 | $17,507,816 | $491,308 | 26 | Jan 14, 2010 | sec.gov |
| May 20, 2009 | New notice | $13,000,000 | $13,000,000 | $0 | 1 | May 14, 2009 | sec.gov |
| Mar 17, 2009 | New notice | $5,000,000 | $2,564,710 | $2,435,290 | 17 | Mar 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles Jeffrey Kim | Director | |
| C. Jeffrey Dekker | Executive Officer | |
| Jerel Jeffrey Banks | Director | |
| Timothy C. Rodell | Director |
Every Form D from the week of Mar 20, 2017 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what GLOBEIMMUNE INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.